Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(1 site)
China
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei